⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
AARDVARK THERAPEUTICS, INC. (AARD) INVESTOR ALERT Investors With Large Losses in Aardvark Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights Ready to Announce with Confidence?
newsfilecorp.com
AARD
AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 Ready to Announce with Confidence?
newsfilecorp.com
AARD
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action
prnewswire.com
AARD
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action
globenewswire.com
AARD
Pomerantz LLP Announces Class Action Lawsuit Filing Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
AARD Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Aardvark Therapeutics, Inc.
prnewswire.com
AARD
Form 8-K
sec.gov
AARD
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
AARD
AARD Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Aardvark Therapeutics, Inc.
businesswire.com
AARD
Kaplan Fox Alerts Aardvark Therapeutics, Inc. (AARD) Investors to a Securities Class Action Deadline on October 13, 2026 Ready to Announce with Confidence?
newsfilecorp.com
AARD